Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.45%
1,082.80
+15.44
+1.45%
1,067.361,073.631,085.941,073.63
SIXC
Communications
SIXC
Communications
SIXC
+0.05%
603.77
+0.29
+0.05%
603.48603.48606.47601.43
SIXE
Energy
SIXE
Energy
SIXE
-2.71%
1,211.19
-33.74
-2.71%
1,244.931,238.101,246.591,210.94
SIXI
Industrials
SIXI
Industrials
SIXI
+1.48%
1,755.99
+25.61
+1.48%
1,730.381,737.301,760.621,737.30
SIXM
Financials
SIXM
Financials
SIXM
-0.15%
638.51
-0.96
-0.15%
639.47639.46643.01636.91
SIXR
Staples
SIXR
Staples
SIXR
-1.40%
842.96
-11.99
-1.40%
854.95854.97855.66842.13
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.33%
219.28
+0.72
+0.33%
218.56218.56220.16218.53
SIXT
Technology
SIXT
Technology
SIXT
+2.66%
3,728.35
+96.76
+2.66%
3,631.593,687.983,744.373,675.71
SIXU
Utilities
SIXU
Utilities
SIXU
-0.03%
915.48
-0.29
-0.03%
915.77917.87921.16915.35
SIXV
Health care
SIXV
Health care
SIXV
-1.02%
1,497.36
-15.45
-1.02%
1,512.811,514.561,514.951,497.36
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.21%
2,413.17
+4.96
+0.21%
2,408.212,418.112,427.232,398.16
009300:KOSDAQ
Sam-A Pharm Co Ltd
₩14,970.00
-1.45%
(-220.00) 1D
May 27, 10:15:40 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 009300...
Open
₩15,250
High
₩15,290
Low
₩14,940
Mkt. cap
95.10B
Avg. vol.
7.99K
Volume
8.39K
Dividend
5.68%
Quarterly dividend
₩213
Ex-dividend date
Dec 27, 2023
P/E ratio
7.06
52-wk high
₩19,250
52-wk low
₩14,730
EPS
₩2,120
Shares outstanding
6.37M
No. of employees
305
News stories
From sources across the web
About Sam-A Pharm Co Ltd
CEOHur Jun
Employees305
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
17.42B
15.11B
20.76B
17.63B
Cost of goods sold
7.00B
6.76B
9.51B
7.45B
Cost of revenue
7.00B
6.76B
9.51B
7.45B
Research and development expenses
2.14B
-
1.52B
1.71B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.69B
9.48B
6.38B
5.81B
Operating expense
8.41B
9.48B
8.60B
8.10B
Total operating expenses
15.41B
16.23B
18.11B
15.55B
Operating income
2.01B
-1.12B
2.65B
2.08B
Other non operating income
1.33B
1.30B
-4.08B
2.03B
EBT including unusual items
3.27B
-26.47M
4.27B
2.98B
EBT excluding unusual items
3.27B
-26.47M
3.35B
2.98B
Income tax expense
581.36M
27.59M
256.69M
748.97M
Effective tax rate
17.76%
-104.23%
6.00%
25.14%
Other operating expenses
-
-
118.33M
-
Net income
2.69B
-54.06M
4.02B
2.23B
Net profit margin
15.46%
-0.36%
19.35%
12.65%
Earnings per share
-
-
-
-
Interest and investment income
-
-
4.89B
-
Interest expense
-
-
-441.06M
-
Net interest expenses
-
-
4.45B
-
Depreciation and amortization charges
568.90M
-
573.84M
574.38M
EBITDA
3.87B
96.62M
3.88B
2.63B
Gain or loss from assets sale
-29.40M
-45.00K
29.44M
-146.71M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more